microRNAs (miRs) are small non-coding RNAs that regulate protein expression by destabilization and/or translational inhibition of target messenger RNAs (mRNAs). Like mRNAs, expression of miRs is regulated in cardiac hypertrophy and heart failure, fine-tuning cardiomyocyte function in response to immediate physiological demands. Single miRs tend to regulate numerous effectors within the same functional pathway, producing a coherent physiological response via multiple parallel perturbations, and are therefore attractive therapeutic targets. However, targeting of dozens or hundreds of different mRNAs by one miR, together with regulated expression of miRs and mRNAs in cardiac disease, complicates delineation of specific miR functions relevant to heart disease. We have developed new techniques combining RNA sequencing on massively parallel next generation platforms with in vivo miR programming of cardiac RNA-induced signaling complexes to overcome this problem. Additionally, we have identified common sequence variants and rare mutations within the mature miR sequence of 30 human miRs and demonstrated that both seed sequence and non-seed sequence miR variants can alter mRNA targeting. Accordingly, we hypothesize that miR effects on the normal and diseased heart are determined by the levels of expressed miRs, the levels of expressed mRNAs, and the efficiency of miR-mRNA pairing as determined by sequence complementarity, and that miR sequence variations further alter miR effects, independent of miR and mRNA expression levels. To examine these hypotheses we propose the first studies to systematically and comprehensively define important miR-mRNA pairing events and determine their functional consequences in genetically programmed mouse hearts under different pathophysiological conditions. We will follow with studies to determining the consequences of human miR sequence variants and mutations on cardiac miR-mRNA targeting, target protein expression, and cardiac structure and function. We are uniquely positioned to achieve these goals by combining our expertise in human genomics, RNA sequencing, and generation and analysis of murine genetic models. It is our long-term goal to integrate studies of human gene variation and cardiac disease with in vitro cell-based and in vivo murine experimental systems to fully understand the impact of miRs on the heart.

Public Health Relevance

microRNAs (miRs) represent an entirely new and unexpected level of biological regulation, targeting mRNA transcripts for degradation or suppression. miRs are dynamically regulated in human cardiac disease. We have found that miR sequence variations, which will affect their binding to and targeting of mRNAs, are surprisingly common in human subjects. Here, we propose studies to define cardiac miR-mRNA interactions in order to better understand miR biology in normal and diseased hearts. These studies will employ novel but fully validated next generation sequencing technologies in combination with state-of-the art in vitro and in vivo functional modeling to translate the clinical observations into mechanistic insights.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Cardiac Contractility, Hypertrophy, and Failure Study Section (CCHF)
Program Officer
Adhikari, Bishow B
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Washington University
Internal Medicine/Medicine
Schools of Medicine
Saint Louis
United States
Zip Code
Dorn 2nd, Gerald W; Matkovich, Scot J (2014) Menage a Trois: intimate relationship among a microRNA, long noncoding RNA, and mRNA. Circ Res 114:1362-5
Dorn 2nd, Gerald W (2014) LIPCAR: a mitochondrial lnc in the noncoding RNA chain? Circ Res 114:1548-50
Matkovich, Scot J; Edwards, John R; Grossenheider, Tiffani C et al. (2014) Epigenetic coordination of embryonic heart transcription by dynamically regulated long noncoding RNAs. Proc Natl Acad Sci U S A 111:12264-9
Dorn 2nd, Gerald W (2013) MicroRNAs and the butterfly effect. Cell Cycle 12:707-8
Dorn 2nd, Gerald W (2013) Mitochondrial dynamism and cardiac fate--a personal perspective. Circ J 77:1370-9
Matkovich, Scot J; Hu, Yuanxin; Dorn 2nd, Gerald W (2013) Regulation of cardiac microRNAs by cardiac microRNAs. Circ Res 113:62-71
Dorn 2nd, Gerald W (2013) miR-34a and the cardiomyopathy of senescence: SALT PNUTS, SALT PNUTS! Cell Metab 17:629-30
Dorn 2nd, Gerald W; Matkovich, Scot J; Eschenbacher, William H et al. (2012) A human 3' miR-499 mutation alters cardiac mRNA targeting and function. Circ Res 110:958-67
Dorn 2nd, Gerald W (2012) Decoding the cardiac message: the 2011 Thomas W. Smith Memorial Lecture. Circ Res 110:755-63